|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_on1005978578 |
| 003 |
OCoLC |
| 005 |
20231120010223.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
171013t20182018maua ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d EBLCP
|d N$T
|d IDEBK
|d OPELS
|d UIU
|d YDX
|d UAB
|d D6H
|d OCLCF
|d MERER
|d OCLCQ
|d ESU
|d U3W
|d LVT
|d OCLCQ
|d UHL
|d OCLCQ
|d OCLCO
|d UK7LJ
|d S2H
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d K6U
|d OCLCQ
|d SFB
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 1006461525
|a 1113778142
|a 1156025081
|
| 020 |
|
|
|a 9780081012758
|q (electronic bk.)
|
| 020 |
|
|
|a 0081012756
|q (electronic bk.)
|
| 020 |
|
|
|z 9780081019252
|
| 020 |
|
|
|z 0081019254
|
| 020 |
|
|
|z 9780081012567
|
| 020 |
|
|
|z 008101256X
|
| 035 |
|
|
|a (OCoLC)1005978578
|z (OCoLC)1006461525
|z (OCoLC)1113778142
|z (OCoLC)1156025081
|
| 050 |
|
4 |
|a R857.N34
|
| 072 |
|
7 |
|a HEA
|x 012000
|2 bisacsh
|
| 072 |
|
7 |
|a HEA
|x 020000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 004000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 101000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 109000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 029000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 040000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 092000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 610.28/4
|2 23
|
| 245 |
0 |
0 |
|a Iron oxide nanoparticles for biomedical applications :
|b synthesis, functionalization and application /
|c editors, Morteza Mahmoudi, Sophie Laurent.
|
| 264 |
|
1 |
|a Cambridge, MA :
|b Elsevier,
|c [2018]
|
| 264 |
|
4 |
|c �2018
|
| 300 |
|
|
|a 1 online resource :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Metal oxides series
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (Ebsco, viewed October 23, 2017).
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Front Cover -- Iron Oxide Nanoparticles for Biomedical Applications: Synthesis, Functionalization and Application -- Copyright -- Contents -- List of Contributors -- Editors' Biography -- Series Editor's Biography -- Preface to the Series -- Part 1: Iron Oxide Nanoparticles -- Chapter 1: Metal Oxide Particles and Their Prospects for Applications -- 1.1. Magnetic Metal Oxides -- 1.2. Metal Oxides With Photoluminescence Properties -- 1.3. Metal Oxides in Electronics, Catalysis, Gas Sensors and Energy Technologies -- 1.3.1. Metal Oxide in Electronics
|
| 505 |
8 |
|
|a 1.3.2. Metal Oxides as Catalysts1.3.3. Metal Oxides in Gas Sensing -- 1.3.4. Metal Oxide in Energy Technologies -- 1.4. Metal Oxides in Biomedical Applications -- 1.4.1. MRI and Cancer Treatment -- 1.4.2. Antibacterial Properties -- 1.4.3. Biomedical Implant -- References -- Further Reading -- Chapter 2: Iron Oxide Nanoparticles for Biomedical Applications: Synthesis, Functionalization, and Application -- 2.1. Iron Nanoparticles: Advantages and Limitations for Biomedical Applications -- 2.1.1. Context -- 2.1.2. Diagnosis -- 2.1.3. Therapy
|
| 505 |
8 |
|
|a 2.2. Synthesis of Iron Oxide Nanoparticles Aimed for Biomedical Applications2.2.1. Overview -- 2.2.2. Understanding the Nanoparticles Formation -- 2.2.2.1. General Principle -- 2.2.2.2. Nucleation/Growth Principle-LaMer Theory -- 2.2.3. Iron Oxide NPs Synthesis by Wet Chemical Methods -- 2.2.3.1. Main Wet Chemical Synthesis Methods -- 2.2.3.2. Thermal Decomposition Synthesis -- Control of the Composition -- Size Control -- Morphology Control: The Case of Cubes -- 2.2.4. Conclusion -- 2.3. Stabilization of the Nanosystems -- 2.3.1. Polymers
|
| 505 |
8 |
|
|a 2.3.2. Dendrimers2.3.2.1. Dendrimer-Stabilized NPs (DSNPs) -- 2.3.2.2. Dendrimer-Assembled NPs (DANPs) -- 2.3.2.3. Dendronized Nanoparticles -- 2.3.3. Nonpolymeric Surface -- 2.4. Methods of IONPs Functionalization for Biomedical Applications -- 2.4.1. Functionalization Strategies as a Function of the NPs Synthesis Method -- 2.4.2. Interaction of Molecules With the Surface of Iron Oxide NPs: Importance of Anchoring Groups -- References -- Part 2: Biomedical Applications -- Chapter 3: Protein Corona: The Challenge at the Nanobiointerfaces -- 3.1. Introduction
|
| 505 |
8 |
|
|a 3.2. The Protein Corona3.3. Hard Versus Soft Corona -- 3.4. Reversible Versus Irreversible Interactions Between NPs and Proteins -- References -- Chapter 4: Nanocytotoxicity -- 4.1. Introduction -- 4.2. Cytotoxicity -- 4.3. Superparamagnetic Iron Oxide Nanoparticles -- References -- Chapter 5: Magnetic Particle Imaging (MPI) -- 5.1. Introduction -- 5.2. Superparamagnetic Iron Oxide Nanoparticles for MPI -- 5.3. Size and Homogeneity -- 5.4. Iron Oxide Nanoparticle Coatings -- References
|
| 650 |
|
0 |
|a Nanomedicine.
|
| 650 |
|
0 |
|a Ferric oxide
|x Magnetic properties.
|
| 650 |
|
0 |
|a Nanoparticles.
|
| 650 |
|
2 |
|a Nanoparticles
|0 (DNLM)D053758
|
| 650 |
|
2 |
|a Nanomedicine
|0 (DNLM)D050997
|
| 650 |
|
6 |
|a Nanoparticules.
|0 (CaQQLa)201-0262530
|
| 650 |
|
6 |
|a Nanom�edecine.
|0 (CaQQLa)201-0448752
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Holism.
|2 bisacsh
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Reference.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Alternative Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Atlases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Essays.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Family & General Practice.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Holistic Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Osteopathy.
|2 bisacsh
|
| 650 |
|
7 |
|a Nanomedicine
|2 fast
|0 (OCoLC)fst01744350
|
| 650 |
|
7 |
|a Nanoparticles
|2 fast
|0 (OCoLC)fst01032624
|
| 700 |
1 |
|
|a Mahmoudi, Morteza,
|d 1979-
|
| 700 |
1 |
|
|a Laurent, Sophie,
|d 1967-
|
| 830 |
|
0 |
|a Metal oxides series.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780081019252
|z Texto completo
|
